CardioMEMS Sets IPO Terms

CardioMEMS Inc., an Atlanta-based developer of wireless medical pressure sensors, has set its proposed IPO terms to 6 million common shares being offered at between $12 and $14 per share. It plans to trade on the Nasdaq under ticker symbol SENS, with Banc of America Securities serving as lead underwriter. The company has raised around $52.6 million in total VC funding from firms like Arcapita, Easton Capital Partners, Boston Millennia Partners, Foundation Medical Partners, Medtronic, Inc. and Johnson and Johnson Development Corp. www.cardiomems.com